Comprehensive Stock Comparison
Compare Oracle Corporation (ORCL) vs Core Scientific, Inc. (CORZ) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | ORCL | 8.4% revenue growth vs CORZ's 1.6% |
| Value | ORCL | Lower P/E (19.7x vs 314.8x) |
| Quality / Margins | ORCL | 25.3% net margin vs CORZ's -229.9% |
| Stability / Safety | ORCL | Beta 1.40 vs CORZ's 2.06 |
| Dividends | ORCL | 1.1% yield; 18-year raise streak; CORZ pays no meaningful dividend |
| Momentum (1Y) | CORZ | +52.1% vs ORCL's -11.2% |
| Efficiency (ROA) | ORCL | 7.5% ROA vs CORZ's -33.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Oracle is a global enterprise software and cloud computing company that provides database management systems, enterprise applications, and cloud infrastructure services. It generates revenue primarily through cloud services and license support (~70% of total revenue) and cloud license and on-premise license sales (~20%), with hardware and services making up the remainder. The company's key moat is its entrenched position in enterprise database software—particularly with its flagship Oracle Database—which creates significant switching costs and lock-in for large corporate customers.
Core Scientific operates large-scale Bitcoin mining facilities and provides colocation hosting services for other miners. It generates revenue primarily from mining Bitcoin for its own account—earning block rewards and transaction fees—and from hosting fees paid by third-party miners who use its infrastructure. The company's competitive advantage lies in its scale, operational expertise, and strategic partnerships with major hardware manufacturers, which provide access to efficient mining equipment.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
ORCL leads in 3 of 6 categories (Financial Metrics, Valuation Metrics). CORZ leads in 1 (Total Returns). 1 tied.
Financial Metrics (TTM)
ORCL is the larger business by revenue, generating $61.0B annually — 182.6x CORZ's $334M. ORCL is the more profitable business, keeping 25.3% of every revenue dollar as net income compared to CORZ's -2.3%. On growth, ORCL holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| RevenueTrailing 12 months | $61.0B | $334M |
| EBITDAEarnings before interest/tax | $22.6B | -$82M |
| Net IncomeAfter-tax profit | $15.4B | -$768M |
| Free Cash FlowCash after capex | -$13.2B | -$354M |
| Gross MarginGross profit ÷ Revenue | +70.7% | +6.5% |
| Operating MarginEBIT ÷ Revenue | +30.3% | -52.1% |
| Net MarginNet income ÷ Revenue | +25.3% | -2.3% |
| FCF MarginFCF ÷ Revenue | -21.6% | -106.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.2% | -14.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +90.9% | +70.5% |
Valuation Metrics
On an enterprise value basis, ORCL's 21.0x EV/EBITDA is more attractive than CORZ's 55.5x.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| Market CapShares × price | $408.1B | $5.2B |
| Enterprise ValueMkt cap + debt − cash | $501.5B | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | 33.50x | -3.30x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.71x | 314.84x |
| PEG RatioP/E ÷ EPS growth rate | 4.72x | — |
| EV / EBITDAEnterprise value multiple | 21.02x | 55.45x |
| Price / SalesMarket cap ÷ Revenue | 7.11x | 10.25x |
| Price / BookPrice ÷ Book value/share | 19.87x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), ORCL scores 6/9 vs CORZ's 5/9, reflecting solid financial health.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| ROE (TTM)Return on equity | +50.6% | — |
| ROA (TTM)Return on assets | +7.5% | -33.5% |
| ROICReturn on invested capital | +12.8% | — |
| ROCEReturn on capital employed | +14.4% | -2.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 4.96x | — |
| Net DebtTotal debt minus cash | $93.3B | $364M |
| Cash & Equiv.Liquid assets | $10.8B | $836M |
| Total DebtShort + long-term debt | $104.1B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | 3.24x | -418.37x |
Total Returns (with DRIP)
A $10,000 investment in CORZ five years ago would be worth $49,331 today (with dividends reinvested), compared to $23,146 for ORCL. Over the past 12 months, CORZ leads with a +52.1% total return vs ORCL's -11.2%. The 3-year compound annual growth rate (CAGR) favors CORZ at 70.2% vs ORCL's 19.9% — a key indicator of consistent wealth creation.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| YTD ReturnYear-to-date | -25.5% | +6.1% |
| 1-Year ReturnPast 12 months | -11.2% | +52.1% |
| 3-Year ReturnCumulative with dividends | +72.3% | +393.3% |
| 5-Year ReturnCumulative with dividends | +131.5% | +393.3% |
| 10-Year ReturnCumulative with dividends | +327.4% | +393.3% |
| CAGR (3Y)Annualised 3-year return | +19.9% | +70.2% |
Risk & Volatility
ORCL is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than CORZ's 2.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CORZ currently trades 71.8% from its 52-week high vs ORCL's 42.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 2.06x |
| 52-Week HighHighest price in past year | $345.72 | $23.63 |
| 52-Week LowLowest price in past year | $118.86 | $6.20 |
| % of 52W HighCurrent price vs 52-week peak | +42.1% | +71.8% |
| RSI (14)Momentum oscillator 0–100 | 41.2 | 52.4 |
| Avg Volume (50D)Average daily shares traded | 20.9M | 8.6M |
Analyst Outlook
Wall Street rates ORCL as "Buy" and CORZ as "Buy". Consensus price targets imply 103.5% upside for ORCL (target: $296) vs 61.3% for CORZ (target: $27). ORCL is the only dividend payer here at 1.14% yield — a key consideration for income-focused portfolios.
| Metric | ORCLOracle Corporation | CORZCore Scientific, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $295.85 | $27.38 |
| # AnalystsCovering analysts | 86 | 22 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | — |
| Dividend StreakConsecutive years of raises | 18 | — |
| Dividend / ShareAnnual DPS | $1.65 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Feb 24 | Feb 26 | Change |
|---|---|---|---|
| Oracle Corporation (ORCL) | 100 | 138.54 | +38.5% |
| Core Scientific, In… (CORZ) | 77.62 | 519.48 | +569.3% |
Core Scientific, In… (CORZ) returned +393% over 5 years vs Oracle Corporation (ORCL)'s +131%. A $10,000 investment in CORZ 5 years ago would be worth $49,331 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Oracle Corporation (ORCL) | $37.0B | $57.4B | +54.9% |
| Core Scientific, In… (CORZ) | $60M | $511M | +757.9% |
Oracle Corporation's revenue grew from $37.0B (2016) to $57.4B (2025) — a 5.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Oracle Corporation (ORCL) | 24.0% | 21.7% | -9.8% |
| Core Scientific, In… (CORZ) | -20.0% | -2.6% | +87.1% |
Oracle Corporation's net margin went from 24% (2016) to 22% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Oracle Corporation (ORCL) | 21.4 | 44.9 | +109.8% |
Oracle Corporation has traded in a 18x–53x P/E range over 9 years; current trailing P/E is ~34x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Oracle Corporation (ORCL) | 2.07 | 4.34 | +109.7% |
| Core Scientific, In… (CORZ) | -0.28 | -5.14 | -1735.7% |
Oracle Corporation's EPS grew from $2.07 (2016) to $4.34 (2025) — a 9% CAGR.
Chart 6Free Cash Flow — 5 Years
Oracle Corporation generated $-394M FCF in 2025 (-103% vs 2021). Core Scientific, Inc. generated $-52M FCF in 2024 (+55% vs 2021).
ORCL vs CORZ: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ORCL or CORZ a better buy right now?
Oracle Corporation (ORCL) offers the better valuation at 33.5x trailing P/E (19.7x forward), making it the more compelling value choice. Analysts rate Oracle Corporation (ORCL) a "Buy" — based on 86 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ORCL or CORZ?
On forward P/E, Oracle Corporation is actually cheaper at 19.7x.
03Which is the better long-term investment — ORCL or CORZ?
Over the past 5 years, Core Scientific, Inc. (CORZ) delivered a total return of +393.3%, compared to +131.5% for Oracle Corporation (ORCL). A $10,000 investment in CORZ five years ago would be worth approximately $49K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CORZ returned +393.3% versus ORCL's +327.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ORCL or CORZ?
By beta (market sensitivity over 5 years), Oracle Corporation (ORCL) is the lower-risk stock at 1.40β versus Core Scientific, Inc.'s 2.06β — meaning CORZ is approximately 47% more volatile than ORCL relative to the S&P 500.
05Which has better profit margins — ORCL or CORZ?
Oracle Corporation (ORCL) is the more profitable company, earning 21.7% net margin versus -257.5% for Core Scientific, Inc. — meaning it keeps 21.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ORCL leads at 30.8% versus -3.8% for CORZ. At the gross margin level — before operating expenses — ORCL leads at 70.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ORCL or CORZ more undervalued right now?
On forward earnings alone, Oracle Corporation (ORCL) trades at 19.7x forward P/E versus 314.8x for Core Scientific, Inc. — 295.1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ORCL: 103.5% to $295.85.
07Which pays a better dividend — ORCL or CORZ?
In this comparison, ORCL (1.1% yield) pays a dividend. CORZ does not pay a meaningful dividend and should not be held primarily for income.
08Is ORCL or CORZ better for a retirement portfolio?
For long-horizon retirement investors, Oracle Corporation (ORCL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.1% yield, +327.4% 10Y return). Core Scientific, Inc. (CORZ) carries a higher beta of 2.06 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ORCL: +327.4%, CORZ: +393.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ORCL and CORZ?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. ORCL pays a dividend while CORZ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.